Beneficial effects of anti-EGFR agents, Cetuximab or Nimotuzumab, in combination with concurrent chemoradiotherapy in advanced nasopharyngeal carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Beneficial effects of anti-EGFR agents, Cetuximab or Nimotuzumab, in combination with concurrent chemoradiotherapy in advanced nasopharyngeal carcinoma

Published:2018-05 Issue: Volume:80 Page:1-8
ISSN:1368-8375
Container-title:Oral Oncology
language:en
Short-container-title:Oral Oncology

Author:

Lin Mei,You Rui,Liu You-Ping,Zhang Yi-Nuan,Zhang Hao-Jiong,Zou Xiong,Yang Qi,Li Chao-Feng,Hua Yi-Jun,Yu Tao,Cao Jing-Yu,Li Ji-Bin,Mo Hao-Yuan,Guo Ling,Lin Ai-Hua,Sun Ying^ORCID,Qian Chao-Nan,Ma Jun,Mai Hai-Qiang,Chen Ming-Yuan

Funder

National Natural Science Foundation of China

New Century Excellent Talents in University

Guangdong Public Welfare Research and Capacity Building Projects

Guangdong Provincial Natural Science Foundation of China

Program of Sun Yat-Sen University for Clinical Research 5010 Program

Major Project of Sun Yat-Sen University for the New Cross Subject

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Oral Surgery

Reference29 articles.

1. Global trends in incidence and mortality of nasopharyngeal carcinoma;Tang;Cancer Lett.,2016

2. Re-evaluation of 6th edition of AJCC staging system for nasopharyngeal carcinoma and proposed improvement based on magnetic resonance imaging;Mao;Int J Radiat Oncol Biol Phys,2009

3. National Comprehensive Cancer Network. NCCN Guidelines: Head and neck cancers; Version2.2017. .

4. A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma;Peng;Radiother Oncol,2012

5. Intensity-modulated radiation therapy versus 2D-RT or 3D-CRT for the treatment of nasopharyngeal carcinoma: a systematic review and meta-analysis;Zhang;Oral Oncol,2015

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The addition of nimotuzumab during concurrent chemoradiotherapy improved survival outcomes in locally advanced nasopharyngeal carcinoma patients with optimal response to induction chemotherapy;BMC Cancer;2024-08-02

2. Preparation and characterization of enzyme-responsive zwitterionic nanoparticles for monoclonal antibody delivery;Frontiers of Materials Science;2023-12

3. Advances of radiotherapy combined with targeted therapy for nasopharyngeal carcinoma;Radiation Medicine and Protection;2023-12

4. Concurrent chemoradiotherapy plus anlotinib vs. concurrent chemoradiotherapy alone in locally advanced nasopharyngeal carcinoma: An interim analysis of a multicenter randomized controlled trial;ONCOL LETT;2023

5. Improving effectiveness using nimotuzumab in patients with nasopharyngeal carcinoma based on the 18F-FDG PET/CT maximum standardized uptake value;2023-04-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3